GeMInI project

The fight against Leishmania, which today affects half a billion of people

The Prince Leopold Institute of Tropical Medicine has for many years been studying the resistance of Leishmania to first-line drugs. With the funds it receives, and based on the research conducted thus far by the two laureates (scholarship recipients for 2008/2010), it has launched the "GeMInI" project, which aims to introduce advanced technologies into the research on neglected tropical diseases. Leishmanioses, which today affect half a billion of people in the Indian sub-continent, will be the priority target of this new integration of advanced molecular techniques into epidemiological research. The GeMInI project can also count on the support from the European Union and research funds from the Flemish Ministry of Economy, Sciences and Innovation. This first study is a model for other clinical aspects of leishmaniosis and other parasitic diseases. It also highlights the close collaboration between the IMT and other research centres such as the Sanger Institute in Glasgow, a pioneer in the sequencing of the human genome, and many other laboratories located in tropical regions. >>>read more: Press release October 2008 PDF file "What is Leishmaniasis ?" PDF file "GeMInI" (in english) PDF file "Scientific Sessions JVG"